Business Update Positive

2026-05-30 11:36

Earkart Limited's Board of Directors approved the incorporation of two new wholly-owned subsidiaries: "Earkart Pharmaceuticals Private Limited" and "Earkart Healthcare Services Private Limited" on May 29, 2026. Earkart Pharmaceuticals will focus on manufacturing, promoting, selling, and distributing pharmaceutical products, while Earkart Healthcare Services will provide services in the healthcare sector. Each subsidiary will have an authorized and paid-up share capital of ₹1,00,000/-.

Financials Positive

2026-05-29 17:18

Earkart Limited announced that its Statutory Auditor, M/s Timsi & Associates, has issued an Audit Report with an unmodified opinion on the Audited Financial Results for the half year and year ended 31 March 2026. The report signifies a clean audit, with results to be published on the company's website.

Financials Negative

2026-05-29 16:36

Earkart Limited announced its Audited Standalone Financial Results for the year ended March 31, 2026. Standalone Revenue was ₹54.04 Cr vs ₹43.11 Cr (▲25.35% YoY), EBITDA was ₹8.35 Cr vs ₹9.76 Cr (▼14.45% YoY), PAT was ₹4.93 Cr vs ₹6.88 Cr (▼28.34% YoY). EBITDA Margin was 15.46% vs 22.65% (▼719bps). The Board also approved the appointment of M/s Arvind Aggarwal & Associates as Internal Auditor and M/s Nikita Kothari & Associates as Secretarial Auditor for FY 2026-27.

Financials Negative

2026-05-29 16:25

Standalone Revenue ₹54.04 Cr vs ₹43.11 Cr (▲25.35% YoY), EBITDA ₹8.46 Cr vs ₹9.85 Cr (▼14.12% YoY), PAT ₹4.93 Cr vs ₹6.88 Cr (▼28.32% YoY). EBITDA Margin 15.65% vs 22.85% (▼720bps). The Board also approved the appointments of M/s Arvind Aggarwal & Associates as Internal Auditor and M/s Nikita Kothari & Associates as Secretarial Auditor for FY 2026-27.

Governance Neutral

2026-05-26 12:55

Earkart Limited announced that its Board of Directors will meet on Friday, 29 May 2026, to consider and approve the audited financial statements for the quarter and financial year ended 31 March 2026, along with the Auditor's Report. The board will also fix the date for the 5th Annual General Meeting. The trading window for the company's listed securities will remain closed until May 31, 2026.

Governance Positive

2026-05-04 13:46

Earkart Limited announced that the resolution for 'CHANGE IN THE OBJECTS FOR UTILIZATION OF THE UNUTILIZED PROCEEDS RAISED FROM THE INITIAL PUBLIC OFFER (IPO) OF THE COMPANY' was passed with 100% of the votes polled in favour by shareholders via remote e-voting, which concluded on May 01, 2026.

Routine Neutral

2026-04-02 17:02

Earkart Limited filed newspaper advertisements for its Postal Ballot Notice and remote e-voting facility, published on April 2, 2026, in Financial Express and Jansatta, complying with SEBI Listing Regulations.

Business Update Positive

2026-04-02 16:24

Earkart Limited proposes re-allocating IPO proceeds via Postal Ballot. Working capital allocation increases, while capital expenditure for SIS reduces. New allocations include ₹250 lakhs for Pharmaceutical Business and ₹600 lakhs for Acquisitions, indicating a strategic shift towards growth.

Governance Neutral

2026-03-30 16:42

Earkart Limited announced the appointment of M/s. Arvind Aggarwal & Associates, Chartered Accountant, as its Internal Auditor for the Financial Year 2025-26, approved by the Board on March 30, 2026.

Ownership Neutral

2026-03-30 15:49

Earkart Limited announced the closure of its trading window from April 1, 2026, for designated persons and insiders. This is ahead of the declaration of Audited Financial Results for the quarter and year ended March 31, 2026, and will remain closed until 48 hours after the results are made public, in compliance with SEBI regulations.

Governance Negative

2026-03-20 16:22

Earkart Limited announced a Board Meeting on March 30, 2026. The agenda includes considering and approving variations in the IPO proceeds' utilization objects and an extension of the time limit for their utilization.

Business Update Neutral

2026-03-11 13:48

CRITICAL RED FLAG DETECTED

Earkart Limited's Board approved land acquisition for a manufacturing facility and a pharmaceutical business acquisition on March 11, 2026. The company also clarified that the board meeting intimation was delayed due to urgency, causing a non-compliance with SEBI regulations, which they regret.

Business Update Positive

2026-02-26 17:08

Earkart Limited announced the incorporation of a wholly-owned subsidiary, Earkart Inc., in Delaware, U.S. on January 20, 2026. This subsidiary will advance the company's business expansion into the U.S. audiology and hearing-care market, a positive step for growth.

Business Update Positive

2026-02-14 15:58

Earkart Limited was awarded a government order worth ₹4.12 Crores from Artificial Limbs Manufacturing Corporation of India (ALIMCO) for BTE Hearing Aids. This order, dated 14th February 2026, is expected to positively contribute to the company's revenue.

Business Update Positive

2026-01-23 11:02

Earkart Limited submitted the transcript of its Valueportal Investor-Company Connect event held on January 20, 2026. Management discussed their patented Omni machine for remote hearing diagnostics, robust sales, the significant market opportunity due to low hearing aid adoption, and plans for growth and international expansion.

Business Update Neutral

2026-01-20 17:45

Earkart Limited's management participated virtually in an investor interaction, "Valueportal Event," on January 20, 2026. The discussion covered the company's business overview, operational performance, growth strategy, and industry outlook. No unpublished price sensitive information was discussed.

Governance Positive

2026-01-14 15:36

Earkart Limited was awarded a government order through the GeM portal on January 14, 2026, valued at ₹2,76,55,844. The order is for TLM Kits (LG95) from ALIMCO.

Governance Positive

2026-01-14 15:21

Earkart Limited was awarded a government order through the GeM portal on January 14, 2026, valued at ₹1.27 crore for TLM Kits (LG94) from ALIMCO. It's a domestic, one-time supply contract.

Routine Neutral

2026-01-13 19:27

EarKart Limited submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025, via Skyline Financial Services. Dated January 13, 2026.

Routine Neutral

2026-01-09 16:19

Earkart Limited announced its participation in the "Valueportal Event" investor interaction on January 20, 2026, from 2:00 PM to 3:00 PM, organized by Finportal Investments. No UPSI will be shared.

544549

EARKART LTD

Filing History

Unlock Full History